Cargando...

Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis

BACKGROUND AND AIM: A large number of studies have tried to combine sorafenib with TACE for patients with unresectable hepatocellular carcinoma (HCC) and the results were controversial. We conducted this systematic review and meta-analysis to evaluate the safety and efficacy of combination therapy o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Liu, Lei, Chen, Hui, Wang, Mengmeng, Zhao, Yan, Cai, Guohong, Qi, Xingshun, Han, Guohong
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961236/
https://ncbi.nlm.nih.gov/pubmed/24651044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0091124
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!